Cravath, Swaine & Moore is serving as legal counsel to Johnson & Johnson, while Skadden is serving as legal counsel to Ambrx Biopharma on the transaction....
Johnson & Johnson’s Acquisition of Ambrx Biopharma
Mirati Therapeutics’ Merger With Bristol Myers Squibb
Kirkland & Ellis LLP advised Bristol Myers Squibb, while Skadden, Arps, Slate, Meagher & Flom LLP advised Mirat on the deal. Bristol Myers Squibb (NYSE: BMY)...
Eli Lilly’s $1.4 Billion Acquisition of POINT Biopharma
Kirkland & Ellis LLP is acting as legal counsel to Lilly, while Skadden, Arps, Slate, Meagher & Flom LLP is acting as legal counsel to POINT...
Intercept Pharmaceuticals’ Merger With Alfasigma
Skadden, Arps, Slate, Meagher & Flom LLP served as legal counsel to Intercept, while Sullivan & Cromwell LLP and Chiomenti Studio Legale, as legal counsel to...
Swedish Orphan Biovitrum’s Acquisition of CTI BioPharma
Skadden and Gibson, Dunn & Crutcher acted as legal advisor on the transaction. CTI BioPharma (Nasdaq: CTIC) (“CTI”) entered into a definitive agreement under which Swedish Orphan...
Astellas’ Acquisition of Iveric Bio
J.P. Morgan Securities LLC, acting through its affiliate JPMorgan Securities Japan Co., Ltd., acted as exclusive financial advisor to Astellas and Jones Day as Astellas’ legal...
GSK’s Acquisition of BELLUS Health
Paul, Weiss, Rifkind, Wharton & Garrison LLP, and Stikeman Elliott LLP advised GSK, while Skadden, Arps, Slate, Meagher & Flom LLP, and Davies Ward Phillips &...
Brookfield Infrastructure’s $13.3 Billion Acquisition of Triton International
Sullivan & Cromwell served as Triton’s legal advisor, with Appleby as Bermuda counsel. Torys and Skadden represented Brookfield Infrastructure Corporation Triton International Limited (NYSE: TRTN) (“Triton”)...
CF Industries’ Acquisition of Waggaman Ammonia Production Facility from Incitec Pivot Limited
Skadden, Arps, Slate, Meagher & Flom represented CF Industries, and Latham & Watkins represented Incitec Pivot. CF Industries Holdings, Inc. (NYSE: CF), a leading global manufacturer...
Alcon’s Acquisition of Aerie Pharmaceuticals
Skadden, Arps, Slate, Meagher & Flom represented Alcon, while Fried, Frank, Harris, Shriver & Jacobson represented Aerie in the transaction. Alcon entered into a definitive merger...
Vertex’s $320 Million Acquisition of ViaCyte
Skadden advised Vertex Pharmaceuticals Incorporated on the deal while Cooley represented ViaCyte. Vertex Pharmaceuticals Incorporated (“Vertex”) has entered into a definitive agreement under which Vertex will acquire...
Halozyme Therapeutics’ Acquisition of Antares Pharma
Weil, Gotshal & Manges advised Halozyme, while Skadden, Arps, Slate, Meagher & Flom advised Antares Pharma on the deal. Fried Frank acted as counsel to BofA...